Chronic inflammatory liver disease: lipid-metabolism enzyme a potential factor in new treatment approach: Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat. Recent studies conducted by MedUni Vienna’s Division of Gastroenterology and Hepatology, under the supervision of Michael Trauner, have shown that the administration of […]
Read More… from Chronic inflammatory liver disease treatment